Medicare Industry Update - New Alzheimer’s Drug Aduhelm

CMS Proposes Medicare Coverage Policy for Aduhelm for the treatment of Alzheimer’s Disease; which means the FDA-approved drug will be covered for people with Medicare, but only if they are enrolled in qualifying clinical trials

For more information you can read the full CMS press release here

Have questions about Aduhelm or how Medicare premiums could be affected? Call us at 800-268-2800.


Recent Posts

AMP, Agent Marketing Portfolio

The Agent Marketing Portfolio (AMP) catalog is an exclusive offer to contracted agents.

Order your custom personalized marketing pieces today! 

Sign In

Your username is the email you registered with.